Nlrx1-KO 基因敲除小鼠

1. Ding, Yaxin, Sun, Wenjie, Han, Mingwei, Wu, Xingan, Liu, Rongrong. 2024. NLRX1: a key regulator in mitochondrial respiration and colorectal cancer progression. In Medical oncology (Northwood, London, England), 41, 131. doi:10.1007/s12032-024-02364-y. https://pubmed.ncbi.nlm.nih.gov/38683455/

2. Guo, Haitao, Wang, Qi, Ghneim, Khader, Su, Lishan, Ting, Jenny P-Y. 2021. Multi-omics analyses reveal that HIV-1 alters CD4+ T cell immunometabolism to fuel virus replication. In Nature immunology, 22, 423-433. doi:10.1038/s41590-021-00898-1. https://pubmed.ncbi.nlm.nih.gov/33767427/

3. Huang, Yu-Ling, Huang, Duen-Yi, Klochkov, Vladlen, Chen, Yuan-Shen, Lin, Wan-Wan. 2024. NLRX1 Inhibits LPS-Induced Microglial Death via Inducing p62-Dependent HO-1 Expression, Inhibiting MLKL and Activating PARP-1. In Antioxidants (Basel, Switzerland), 13, . doi:10.3390/antiox13040481. https://pubmed.ncbi.nlm.nih.gov/38671928/

4. Qin, Yuwen, Xue, Binbin, Liu, Chunyan, Yang, Darong, Zhu, Haizhen. 2017. NLRX1 Mediates MAVS Degradation To Attenuate the Hepatitis C Virus-Induced Innate Immune Response through PCBP2. In Journal of virology, 91, . doi:10.1128/JVI.01264-17. https://pubmed.ncbi.nlm.nih.gov/28956771/